Fortrea Holdings (FTRE) Divestments (2024 - 2025)

Fortrea Holdings (FTRE) posted Divestments of $20.6 million for Q3 2025, up 8.42% on a QoQ basis from $19.0 million in Q1 2025, and up 339.53% year-over-year from $4.7 million in Q3 2024.

Fortrea Holdings (FTRE) Divestments (2024 - 2025) Analysis & Trends

Fortrea Holdings' Divestments history runs 2 years deep, the most recent figure standing at $20.6 million for Q3 2025.

  • Quarterly Divestments rose 339.53% year-over-year to $20.6 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $20.6 million (down 93.03% YoY) and the FY2025 annual result came in at $39.6 million, down 85.68% from the prior year.
  • Divestments was $20.6 million for Q3 2025 at Fortrea Holdings, up from $19.0 million in the prior quarter.
  • Across five years, Divestments topped out at $285.2 million in Q2 2024 and bottomed at -$8.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 20.60 Mn
Mar 31, 2025 19.00 Mn
Sep 30, 2024 -8.60 Mn
Jun 30, 2024 285.20 Mn